<?xml version='1.0' encoding='utf-8'?>

<rss version="2.0">
  <channel>
    <title>The Federal Register</title>
    <link>http://thefederalregister.com/b.p/agency/Drug_Enforcement_Administration/2007-12-10/</link>
    <description>Daily Publications of Meetings and Rules Changes for the Federal Government</description>
    <pubDate>Sun, Sep 7 2008 11:00:00 GMT</pubDate>
    <lastBuildDate>Sun, Sep 7 2008 11:00:00 GMT</lastBuildDate>
    <webMaster>info@thefederalregister.com</webMaster>
    <item>
  <title><![CDATA[  Designation of Oripavine as a Basic Class of Controlled  Substance; Correction]]></title>
  <link>http://thefederalregister.com/d.p/2007-12-10-E7-23759</link>
  <description><![CDATA[ On September 24, 2007, the Drug Enforcement Administration 
(DEA) published in the Federal Register a final rule (72 FR 54208) 
designating oripavine (3Odemethylthebaine or 6,7,8,14tetradehydro
4,5alphaepoxy6methoxy17methylmorphinan3ol) as a basic class in 
schedule II of the Controlled Substances Act (CSA). The drug code for 
oripavine was inadvertently designated as 9335, a drug code which is 
already used to identify a schedule I controlled substance. This 
correction corrects that error and assigns a different drug code to 
oripavine.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2007-12-10-E7-23759</guid>
  <pubDate>Mon, Dec 10 2007 11:00:00 GMT</pubDate>
</item>
</channel>
</rss>

